Ernexa Therapeutics Inc.
BiotechnologyCell Therapy, Biotechnology
Cambridge, MA
About
Ernexa Therapeutics Inc. is a biotechnology company focused on developing cell therapy solutions for advanced cancer and autoimmune diseases. They use induced pluripotent stem cells (iPSCs) to create induced mesenchymal stem cells (iMSCs) with unique targeting capabilities, enabling the creation of scalable, off-the-shelf therapies. This method eliminates the need for patient-specific solutions.
Company Values
Scalable iPSC-derived iMSC therapies